This podcast has been funded by Advanz pharma
The views and opinions expressed in this podcast are those of the individual speakers and do not necessarily reflect those of Advanz pharma or EMJ.
This webinar explores biosimilars and their applications in clinical practice. Our moderator Sue Saville is joined by leading experts: rheumatologist Gerd Burmester and ophthalmologist Luke Nicholson, who explain what biosimilars are and explore how they are transforming healthcare in their respective fields. The discussion also highlights how biosimilar medications expand access to vital treatments, particularly in resource-limited settings.
Moderator
Sue Saville1
1. Independent Healthcare Communications Specialist
Speakers
Gerd Burmester2
Luke Nicholson3
2. Gerd Burmester is a leading rheumatologist and immunologist from Charité University Clinic in Berlin, Germany. He specialises in understanding and reprogramming the human immune system, with a focus on the molecular pathways that drive autoimmunity, particularly in rheumatoid arthritis.
3. Luke Nicholson is a leading consultant ophthalmic surgeon from Moorfields and Moorfields Private Eye Hospitals in London, UK. He specialises in retinal conditions, with a particular focus on retinal vein occlusion and diabetic retinopathy.
